8 July 2019 - The former managing director of Dropbox Australia, a Microsoft Health executive and an early Atlassian employee are among the seed investors in Rosemary, a start-up that has created an app to help the millions of Australians struggling to manage their medications.

Better management of medicines can improve their efficacy and reduce waste. The app could also help the 5660-plus community-based pharmacies around Australia to compete better with giant chains such as Chemist Warehouse, not to mention US-giant Amazon which entered the US pharmacy market in 2018, and has grand ambitions in the sector.

Rosemary will make money by charging the pharmacist a small fee on each script processed using the system, while the patient may be charged a small delivery fee depending on the value of the therapeutic.

Read Australian Financial Review article